Daria B Crittenden

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
    J Rheumatol 39:1458-64. 2012
  2. doi request reprint New therapies for gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, Department of Medicine, NYU School of Medicine NYU Langone Medical Center, New York, New York 10003, USA
    Annu Rev Med 64:325-37. 2013
  3. doi request reprint Prevalence of contraindications and prescription of pharmacologic therapies for gout
    Robert T Keenan
    Section of Rheumatology of the New York Harbor Health Care System, New York Campus of the US Department of Veterans Affairs, New York, USA
    Am J Med 124:155-63. 2011
  4. ncbi request reprint The year in gout: 2011-2012
    Daria B Crittenden
    Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 70:145-51. 2012
  5. doi request reprint Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street
    Elaine Karis
    From the Division of Rheumatology, Crystal Diseases Study Group, New York University School of Medicine Langone Medical Center, and the Department of Medicine, Rheumatology Section, New York Harbor Veterans Affairs Healthcare System, New York, New York
    South Med J 107:235-41. 2014
  6. pmc The crystallization of monosodium urate
    Miguel A Martillo
    Divisions of Rheumatology, Department of Medicine, NYU School of Medicine, New York, USA
    Curr Rheumatol Rep 16:400. 2014
  7. ncbi request reprint The year in gout - 2010-2011
    Daria B Crittenden
    Rheumatology Section, New York Harbor VA Healthcare System New York Campus, New York, New York, USA
    Bull NYU Hosp Jt Dis 69:257-63. 2011

Collaborators

Detail Information

Publications7

  1. pmc Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, New York University School of Medicine, New York, New York 10003, USA
    J Rheumatol 39:1458-64. 2012
    ..We examined whether colchicine use was associated with a reduced risk of myocardial infarction (MI) in patients with gout...
  2. doi request reprint New therapies for gout
    Daria B Crittenden
    Crystal Diseases Study Group, Division of Rheumatology, Department of Medicine, NYU School of Medicine NYU Langone Medical Center, New York, New York 10003, USA
    Annu Rev Med 64:325-37. 2013
    ..These new treatments do not obviate the need for lifestyle and dietary management, another area in which significant scientific and clinical progress has recently been made...
  3. doi request reprint Prevalence of contraindications and prescription of pharmacologic therapies for gout
    Robert T Keenan
    Section of Rheumatology of the New York Harbor Health Care System, New York Campus of the US Department of Veterans Affairs, New York, USA
    Am J Med 124:155-63. 2011
    ..Patients with gout have comorbidities, but the impact of these comorbidities on treatment has not been studied...
  4. ncbi request reprint The year in gout: 2011-2012
    Daria B Crittenden
    Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA
    Bull NYU Hosp Jt Dis 70:145-51. 2012
    ..Here we review some of the most important recent advances in gout over the past 12 to 18 months...
  5. doi request reprint Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street
    Elaine Karis
    From the Division of Rheumatology, Crystal Diseases Study Group, New York University School of Medicine Langone Medical Center, and the Department of Medicine, Rheumatology Section, New York Harbor Veterans Affairs Healthcare System, New York, New York
    South Med J 107:235-41. 2014
    ..The evidence that gout and hyperuricemia contribute to the pathogenesis of their comorbidities creates greater urgency for appropriate gout management. ..
  6. pmc The crystallization of monosodium urate
    Miguel A Martillo
    Divisions of Rheumatology, Department of Medicine, NYU School of Medicine, New York, USA
    Curr Rheumatol Rep 16:400. 2014
    ..We also briefly compare MSU biology to that of uric acid stones causing nephrolithasis, and consider the potential treatment implications of MSU crystal biology. ..
  7. ncbi request reprint The year in gout - 2010-2011
    Daria B Crittenden
    Rheumatology Section, New York Harbor VA Healthcare System New York Campus, New York, New York, USA
    Bull NYU Hosp Jt Dis 69:257-63. 2011
    ....